| 5501 |
Apheresis |
Allogeneic
|
No Data
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
58 |
| 5502 |
Apheresis |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
68 |
| 5503 |
Apheresis |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
28 |
| 5504 |
Apheresis |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
58 |
| 5505 |
Apheresis |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
67 |
| 5506 |
Apheresis |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
51 |
| 5507 |
Apheresis |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
65 |
| 5508 |
Apheresis |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
42 |
| 5509 |
Apheresis |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
55 |
| 5510 |
Apheresis |
Autologous
|
Non-Hodgkin Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
56 |
| 5511 |
Apheresis |
Autologous
|
Non-Hodgkin Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
59 |
| 5512 |
Apheresis |
Autologous
|
Non-Hodgkin-Lymphoma-Relapse
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
63 |
| 5513 |
Apheresis |
Autologous
|
Non-Hodgkin-Lymphoma-Relapse
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
69 |
| 5514 |
Apheresis |
Allogeneic
|
Osteomyelofibrosis – Other
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
63 |
| 5515 |
Apheresis |
Allogeneic
|
Other Myelofibrosis
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
70 |
| 5516 |
Apheresis |
Allogeneic
|
Other Myelofibrosis
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
61 |
| 5517 |
Apheresis |
Allogeneic
|
Other Myelofibrosis
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
50 |
| 5518 |
Apheresis |
Allogeneic
|
Paroxysmal Nocturnal Hemoglobinuria (Pnh)
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
24 |
| 5519 |
Apheresis |
Allogeneic
|
Plasma Cell Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
35 |
| 5520 |
Apheresis |
Allogeneic
|
Polycythemia Vera-Myelofibrosis
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
58 |
| 5521 |
Apheresis |
Allogeneic
|
Post–Polycythemia Vera Myelofibrosis
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
70 |
| 5522 |
Apheresis |
Autologous
|
Primary Central Nervous System Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
65 |
| 5523 |
Apheresis |
Autologous
|
Primary Central Nervous System Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
63 |
| 5524 |
Apheresis |
Autologous
|
Primary Central Nervous System Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
69 |
| 5525 |
Apheresis |
Autologous
|
Primary Central Nervous System Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
64 |
| 5526 |
Apheresis |
Autologous
|
Primary Central Nervous System Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
56 |
| 5527 |
Apheresis |
Autologous
|
Primary Central Nervous System Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
57 |
| 5528 |
Apheresis |
Autologous
|
Primary Central Nervous System Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
63 |
| 5529 |
Apheresis |
Autologous
|
Primary Central Nervous System Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
67 |
| 5530 |
Apheresis |
Autologous
|
Primary Central Nervous System Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
78 |
| 5531 |
Apheresis |
Allogeneic
|
Primary Immunodeficiency
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
21 |
| 5532 |
Apheresis |
Allogeneic
|
Primary Immunodeficiency
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
19 |
| 5533 |
Apheresis |
Allogeneic
|
Primary Mediastinal
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
33 |
| 5534 |
Apheresis |
Allogeneic
|
Primary Myelofibrosis
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
46 |
| 5535 |
Apheresis |
Allogeneic
|
Primary Myelofibrosis
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
45 |
| 5536 |
Apheresis |
Allogeneic
|
Primary Myelofibrosis
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
55 |
| 5537 |
Apheresis |
Allogeneic
|
Relapsed Peripheral T Cell Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
65 |
| 5538 |
Apheresis |
Allogeneic
|
Secondary Acute Myeloid Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
59 |
| 5539 |
Apheresis |
Allogeneic
|
Secondary Acute Myeloid Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
64 |
| 5540 |
Apheresis |
Allogeneic
|
Secondary Acute Myeloid Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
60 |
| 5541 |
Apheresis |
Allogeneic
|
Secondary Acute Myeloid Leukemia At Myeloproliferative Neoplasms
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
56 |
| 5542 |
Apheresis |
Autologous
|
Secondary Primary Central Nervous System Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
66 |
| 5543 |
Apheresis |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
12 |
| 5544 |
Apheresis |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
11 |
| 5545 |
Apheresis |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
55 |
| 5546 |
Apheresis |
Allogeneic
|
Severe Combined Immunodeficiency
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
1 |
| 5547 |
Apheresis |
Allogeneic
|
T-Cell Acute Lymphoblastic Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
44 |
| 5548 |
Apheresis |
Autologous
|
T-Cell Non-Hodgkin Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
55 |
| 5549 |
Apheresis |
Autologous
|
T-Cell Non-Hodgkin Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
59 |
| 5550 |
Apheresis |
Allogeneic
|
T-Cell Non-Hodgkin Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
67 |
| 5551 |
Apheresis |
Allogeneic
|
T-Cell Non-Hodgkin Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
45 |
| 5552 |
Apheresis |
Autologous
|
T-Cell Non-Hodgkin Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
72 |
| 5553 |
Apheresis |
Autologous
|
T-Cell Non-Hodgkin Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
61 |
| 5554 |
Apheresis |
Autologous
|
T-Cell Non-Hodgkin Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
61 |
| 5555 |
Apheresis |
Autologous
|
Testicular Cancer Relapse
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
29 |
| 5556 |
Apheresis |
Allogeneic
|
Thalassemia Major
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
20 |
| 5557 |
Apheresis |
Allogeneic
|
Wiskott-Aldrich Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
1 |
| 5558 |
Apheresis |
Allogeneic
|
Β – Thalassemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
13 |
| 5559 |
Adipose Tissue |
Autologous
|
Chondromalacia
|
Orthopedy
|
2019
|
Experimental Therapy
|
Poland
|
48 |
| 5560 |
Adipose Tissue |
Autologous
|
Chondromalacia
|
Orthopedy
|
2019
|
Experimental Therapy
|
Poland
|
38 |
| 5561 |
Adipose Tissue |
Autologous
|
Coxarthrosis
|
Orthopedy
|
2019
|
Experimental Therapy
|
Poland
|
34 |
| 5562 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2019
|
Clinical Trial
|
Poland
|
0 |
| 5563 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2019
|
Clinical Trial
|
Poland
|
0 |
| 5564 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2019
|
Clinical Trial
|
Poland
|
0 |
| 5565 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2019
|
Clinical Trial
|
Poland
|
0 |
| 5566 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2019
|
Clinical Trial
|
Poland
|
0 |
| 5567 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2019
|
Clinical Trial
|
Poland
|
0 |
| 5568 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2019
|
Clinical Trial
|
Poland
|
0 |
| 5569 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2019
|
Clinical Trial
|
Poland
|
0 |
| 5570 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2019
|
Clinical Trial
|
Poland
|
0 |
| 5571 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2019
|
Clinical Trial
|
Poland
|
0 |
| 5572 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2019
|
Clinical Trial
|
Poland
|
0 |
| 5573 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2019
|
Clinical Trial
|
Poland
|
0 |
| 5574 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2019
|
Clinical Trial
|
Poland
|
0 |
| 5575 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2019
|
Clinical Trial
|
Poland
|
0 |
| 5576 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2019
|
Clinical Trial
|
Poland
|
0 |
| 5577 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2019
|
Clinical Trial
|
Poland
|
0 |
| 5578 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2019
|
Clinical Trial
|
Poland
|
0 |
| 5579 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2019
|
Clinical Trial
|
Poland
|
0 |
| 5580 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2019
|
Clinical Trial
|
Poland
|
0 |
| 5581 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2019
|
Clinical Trial
|
Poland
|
0 |
| 5582 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2019
|
Clinical Trial
|
Poland
|
0 |
| 5583 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2019
|
Clinical Trial
|
Poland
|
0 |
| 5584 |
Adipose Tissue |
Autologous
|
Cutis Laxa
|
Dermatology
|
2019
|
Clinical Trial
|
Poland
|
0 |
| 5585 |
Adipose Tissue |
Autologous
|
Gonarthrosis
|
Orthopedy
|
2019
|
Experimental Therapy
|
Poland
|
44 |
| 5586 |
Adipose Tissue |
Autologous
|
Gonarthrosis
|
Orthopedy
|
2019
|
Experimental Therapy
|
Poland
|
65 |
| 5587 |
Adipose Tissue |
Autologous
|
Gonarthrosis
|
Orthopedy
|
2019
|
Experimental Therapy
|
Poland
|
68 |
| 5588 |
Adipose Tissue |
Autologous
|
Gonarthrosis
|
Orthopedy
|
2019
|
Experimental Therapy
|
Poland
|
36 |
| 5589 |
Adipose Tissue |
Autologous
|
Gonarthrosis
|
Orthopedy
|
2019
|
Experimental Therapy
|
Poland
|
54 |
| 5590 |
Adipose Tissue |
Autologous
|
Mild Arthritis
|
Orthopedy
|
2019
|
Experimental Therapy
|
Poland
|
21 |
| 5591 |
Adipose Tissue |
Autologous
|
Mild Arthritis
|
Orthopedy
|
2019
|
Experimental Therapy
|
Poland
|
68 |
| 5592 |
Adipose Tissue |
Autologous
|
Osteoarthritis
|
Orthopedy
|
2019
|
Experimental Therapy
|
Poland
|
52 |
| 5593 |
Adipose Tissue |
Autologous
|
Osteoarthritis
|
Orthopedy
|
2019
|
Experimental Therapy
|
Poland
|
44 |
| 5594 |
Adipose Tissue |
Autologous
|
Osteoarthritis
|
Orthopedy
|
2019
|
Experimental Therapy
|
Poland
|
52 |
| 5595 |
Adipose Tissue |
Autologous
|
Osteoarthritis
|
Orthopedy
|
2019
|
Experimental Therapy
|
Poland
|
54 |
| 5596 |
Adipose Tissue |
Autologous
|
Osteoarthritis
|
Orthopedy
|
2019
|
Experimental Therapy
|
Poland
|
55 |
| 5597 |
Adipose Tissue |
Autologous
|
Scar
|
Dermatology
|
2019
|
Clinical Trial
|
Poland
|
0 |
| 5598 |
Adipose Tissue |
Autologous
|
Scar
|
Dermatology
|
2019
|
Clinical Trial
|
Poland
|
0 |
| 5599 |
Adipose Tissue |
Autologous
|
Scar
|
Dermatology
|
2019
|
Clinical Trial
|
Poland
|
0 |
| 5600 |
Adipose Tissue |
Autologous
|
Scar
|
Dermatology
|
2019
|
Clinical Trial
|
Poland
|
0 |